guidance for working with hospitals / how prototypes move off campus
Marty brought up an important point that will become rate-limiting for face shields (and other projects) in the coming week: how do we get prototypes out to hospitals? What about pilot-scale production runs? It sounds like Elazer and team is setting up an official process for moving MIT-produced prototypes into clinical settings -- how does this process work?
Per the discussion this morning, after collecting feedback I will instruct my hospital contact to return the prototypes we have supplied and will hold off on any iterations that leave our facility until receiving further guidance here.